As a part of a study testing out a new type of implanted brain-computer interface (BCI), three rhesus monkeys controlled ...
Polaryx Therapeutics, Inc. (Nasdaq: PLYX), a clinical-stage biotechnology company developing disease-modifying therapies for rare pediatric LSDs, today announced that the U.S. Food and Drug ...
Opinion: Federal courts in Texas are making clear that immunity isn’t a status-based entitlement for hospitals—it's a ...
As published in The Lancet and presented at AAN, NIMBLE trial met its primary and key secondary endpoints at week 24, demonstrating potential best-in-class efficacy and convenience in gMG ...
WH editors tested 60 bestselling, sex therapist-recommended vibrators to narrow down the best bullet vibrators, rabbit vibrators, and more for women in 2026.
Processor architectures are evolving faster than ever, but they still lag the pace of AI development. Chip architects must ...
These results underscore that fenebrutinib has potential as a high-efficacy oral treatment for RMS. Its unique mode of action may offer a differentiated profile by targeting dual drivers of MS within ...
These are just two common myths floating around the time period after a person gives birth, known as postpartum. Christine Feigal, MD, a board-certified OB/GYN and vice chair of the OB/GYN Department ...
A unit of Goldman Sachs Asset Management invested $50 million in BLP Digital, a Swiss artificial intelligence company that ...
John Ternus was the center of speculation as being the best and most likely choice for the next Apple CEO, and those ...
The Tribunal held that the Indian entity was only a distributor and not a technology or content owner. It rejected the Revenue’s attempt to recharacterise the business and apply royalty-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results